Doctor of Dentistry Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Michael Bobo

Dentist, Oral and Maxillofacial Surgery Murray, KY Doctor of Dentistry

NPI 1417031436 CMS profile 63980

1109 Poplar Street, Murray, KY 42071

Open in the dashboard

General payments

$501

21 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Michael Bobo of Murray, KY is reported in the CMS Open Payments database as having received $501 across 21 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 43rd percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $21 1
2022 General $114 4
2021 General $128 7
2020 General $47 3
2019 General $192 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Bobo
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Michael Bobo were reported at $0. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Michael Bobo Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $192 $142 $50–$420 $163
2020 $47 $96 $36–$277 $114
2021 $128 $138 $45–$419 $132
2022 $114 $144 $48–$367 $149
2023 $21 $153 $55–$399 $160
2024 $0 $152 $50–$400 $164
2025 $0 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Straumann USA LLC $331 13 payments
  2. Medtronic, Inc. $66 2 payments
  3. Zimmer Biomet Holdings, Inc. $56 4 payments
  4. Zimvie Inc. $48 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $319 17 payments
  2. Education $100 1 payment
  3. Gift $62 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21 1 payment
Products named General payments · program years 2019–2023
  1. Situate $66 2 payments
  2. Puros Dental $45 3 payments
  3. Tapered Screw-Vent $28 1 payment
  4. Puros Dental $11 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

543

Median for Oral Surgery (Dentist only): 288

Drug cost

$1,992

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

65.2%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 254 $963
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 100 $293
Chlorhexidine Gluconate Generic 76 $275
Dexamethasone Generic 12 $176
Amoxicillin Generic 60 $135
Cephalexin Generic 18 $131
Tramadol Hcl Generic 23 $18

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$8,926

Medicare's payments for the services billed

Medicare patients

47

Average age 75

Services billed

90

27 women, 20 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Diabetes 32%
Chronic kidney disease 30%
Ischemic heart disease 26%
Cancer 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

21 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record